Individuals with kidney failure and those who have received a kidney transplant are especially vulnerable to COVID-19 and are thought to have a higher risk of dying from it than adults in the general population. Although ...
Sep 29, 2021
0
10
A study by researchers at the Rutgers Ernest Mario School of Pharmacy finds that melatonin significantly reduces kidney failure in people being treated with the antibiotic vancomycin.
Sep 15, 2021
0
142
Patients with kidney failure who are on long-term dialysis often rely on family members or friends to make critical treatment decisions towards the end of life. A study in CJASN examines whether such close contacts have a ...
Sep 10, 2021
0
6
(HealthDay)—Current chronic kidney disease (CKD) definitions that do not consider age-related estimated glomerular filtration rate (eGFR) decline may inflate the burden of CKD in the elderly, according to a study published ...
Sep 8, 2021
0
12
The Patient Activation Measure (PAM) is a standardized instrument that assesses an individual's knowledge, ability, skills, and confidence in self-managing chronic medical conditions. A study published in JASN examined whether ...
Sep 1, 2021
0
2
Finerenone reduces the risk of cardiovascular morbidity and mortality in patients with mild-to-moderate kidney disease and type 2 diabetes. That's the finding of late breaking research presented in a Hot Line session today ...
Aug 30, 2021
0
4
(HealthDay)—Current guidelines for nephrology referral identify many patients at low risk for progression, according to a study published online Aug. 24 in the American Journal of Kidney Diseases.
Aug 25, 2021
0
98
Staying well hydrated throughout life could reduce the risk of developing heart failure, according to research presented at ESC Congress 2021.
Aug 24, 2021
0
548
Despite impacting an estimated 850 million people and being responsible for 1 in 60 deaths worldwide, few treatments are available for chronic kidney disease. Understanding the genetic variations associated with the disease ...
Aug 13, 2021
0
364
(HealthDay)—Use of pharmacomechanical thrombolysis (PMT) for treatment of acute deep vein thrombosis (DVT) is associated with a risk for acute kidney injury (AKI) that can progress to chronic renal failure in some patients, ...
Aug 5, 2021
0
96
